drugset / Trial / NCT01579578
Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to assess the efficacy and safety and PK of AZD8931 plus paclitaxel versus paclitaxel alone in patients with metastatic, gastric or gastro-oesophageal junction, cancer.
Timeline
- Start
- 2012-04
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SAPITINIB | Small molecule | 40 mg | Oral |
| Background | Paclitaxel | Small molecule | — | Intravenous |